Columnist Teri Sforza writes that studies have found that the popular weight-loss and diabetes drugs reduced alcohol intake, ...

GLP-1 drugs for diabetes and weight loss may influence patients’ cancer risk, usually lowering it but sometimes possibly ...

Serena Williams reveals her use of GLP-1, Zepbound and calls out the stigma surrounding the use of the popular weight loss ...

Studies have found that semaglutide, the chemical in Ozempic, reduced alcohol intake, binge drinking and relapse ...

A NEW drug developed to combat diabetes and obesity melts fat at double the rate of other GLP-1 drugs, scientists say. The ...

Mounjaro and other GLP-1 drugs may lower cancer risk in obese patients, according to a new study. Read more here.

So the, the question we're investigating in this study is whether the use of GLP-1 receptor agonists, which is *** medication for weight loss and diabetes, um, is associated with ...

Employers and benefits advisors are facing a growing challenge: How to offer access to these high-demand, life-changing ...

Serena Williams recently shared that she started taking the GLP-1 drug Zepbound after having her two children. The tennis ...

New research reveals that GLP-1 receptor agonists significantly lower mortality risk in older cancer patients with type 2 ...

In an effort to address the state’s obesity epidemic and subsequently address the health effects associated with it, the ...

Diabetes drug Ozempic will cost half-price for US patients paying cash - The drug is available as a weight-loss medication under the brand name Wegovy and will now also be sold directly to diabetes pa ...